31 results about "Small intestinal motility" patented technology

The invention discloses compound functional sugar with a function of adjusting intestinal flora. The compound functional sugar contains functional oligosaccharide, L-arabinose, dietary fiber and probiotics and is characterized in that bifidobacterium, lactobacillus and other beneficial bacteria can be proliferated; meanwhile, the proliferation of escherichia coli, enterococcus and other harmful bacteria is restrained to adjust the intestinal flora; and the small intestine peristalsis can be promoted, the defecating time can be shortened, the defecation quantity can be increased to play a role in defaecation.

The invention discloses bifidobacterium bifidum capable of remarkably relieving constipation and application thereof and belongs to the technical field of microorganisms. The bifidobacterium bifidum CGMCC NO.13632 can well tolerate simulative gastrointestinal fluid, can be well attached to colon cancer cells HT-29, and can remarkably increase the water content of excrement of constipation mice and shorten the first tarry stool time. On the aspect of increasing the small intestine driving rate, the bifidobacterium bifidum CGMCC NO.13632 is superior to cathartic phenolphthalein, a best effect is shown, secretion of gastrointestinal regulatory peptide relevant to constipation in serum is also adjusted while constipation pathological factors are remarkably improved, and the bifidobacterium bifidum does not have toxic and side effects of medicine for treating constipation, and is a first choice for preventing and treating constipation. The bifidobacterium bifidum CGMCC NO.13632 is used for preparing pharmaceutical compositions and fermented food for relieving constipation, and has very wide application prospects.

The invention discloses bifidobacterium bifidum for relieving constipation as well as a fermented food and a probiotic preparation prepared from the bifidobacterium bifidum, and belongs to the technical field of microorganisms. The Bifidobacterium bifidum CCFM1167 provided by the invention can be used for effectively relieving the first black stool time, the intestinal tract propulsion rate and the water content of stool of a mouse with constipation, and has the effect of obviously improving the apparent pathological indexes of constipation; in the detection of physicochemical indexes, the bifidobacterium bifidum can also influence the content of gastrointestinal active peptides, so that the intestinal peristalsis is influenced; the bifidobacterium bifidum also can effectively relieve pathological injury of colon tissues so as to effectively relieve constipation symptoms, and compared with bifidobacterium longum GDMCC NO: 60941, the bifidobacterium bifidum has more obvious influence on MTL content, further has more obvious effect on increasing the small intestine propulsion rate, and is more suitable for constipation patients with weak small intestine propulsion.

The invention discloses a bifidobacterium bifidum for relieving constipation and regulating intestinal flora disorder and application thereof, and belongs to the field of microorganisms. The bifidobacterium bifidum provided by the invention can obviously improve the water content of excrement and the intestinal propulsive rate and reduce the first black excrement time of constipation mice, and has the effect of obviously improving apparent pathological indexes of constipation; in the detection of physiological indexes, the bifidobacterium bifidum can also improve the content of motilin and reduce the content of somatostatin, so that the intestinal tract movement is fundamentally influenced; the bifidobacterium bifidum can regulate the abundance of important microorganisms in the intestinal tract and maintain the steady state of the intestinal tract. Compared with GDMCC NO: 60940, the bifidobacterium bifidum CCFM1166 has the advantages that the content of MTL in serum is better increased, the content of SS in the serum is reduced, and the promotion effect on intestinal peristalsis is more remarkable, so that a more personalized treatment scheme can be adopted for constipation patients in the future, and the application prospect is very considerable.

The invention discloses a plant wine or drink prompting digestion, and particularly relates to a large-fruited Chinese hawthorn appetizer wine or drink and a preparation method thereof. The large-fruited Chinese hawthorn appetizer wine or drink is prepared from Chinese hawthorn fruits, fried malt, pericarpium citri reticulatae, fried radish seeds, fennel, fructus citrus sarcodactylis, fructus hippophae, liquorice roots, cassia bark, xylooligosaccharide, potassium sorbate, and baijiu with the alcohol content of 38% or grape wine or water. The composition has the obvious effect of increasing the total gastric juice amount, the gastric juice discharge amount and the pepsase discharge amount and the obvious effect of increasing the small intestine propulsion speed of a mouse slow gastrointestinal motility model, which shows that the composition has the effects of promoting digestion and promoting gastrointestinal motility. The large-fruited Chinese hawthorn appetizer wine or drink has the advantages of being safe, effective, free of side effects and the like. The modern advanced ultrasonic extraction technology is adopted for preparing the large-fruited Chinese hawthorn appetizer wine or drink, so that the utilization rate of effective constituents of plants is significantly increased, and energy conservation and environment protection are achieved; radish seeds are subjected to quantitative microwave frying, and the large-fruited Chinese hawthorn appetizer wine or drink is suitable for industrial production, is novel and can fill up the blank of appetizer wine in China.

The invention discloses a health care product with a function of relaxing bowels and a preparation method thereof. The health care product is prepared from the following raw materials in parts by weight: 100-300 parts of Chinese angelica, 200-600 parts of milkvetch roots, 150-450 parts of largehead atractylodes rhizomes, 150-450 parts of plantago ovata seed shell, 250-750 parts of fructus cannabis, 100-300 parts of cassia seeds and the like. According to the theory of traditional Chinese medicines and the pathogenesis of constipation, the raw materials are selected for compound and compatibility. Particularly, plantago ovata seed shell powder is added to be mixed with the traditional Chinese medicines according to a specific proportion, so that a synergistic effect can be exerted, and theproportion of the components is scientific and reasonable. Experimental results show that the health-care product provided by the invention has effects of promoting small intestine propulsion and emptying movement, can promote gastrointestinal motility and has a good defecation promoting effect.

The invention provides a medicine for quickly treating anorexia of infants. The medicine is prepared by the following Chinese herbal medicines: endothelium corneum gigeriae galli, scorpio, wrinkled gianthyssop herbs, fructus amomi, spina gleditsiae, clove, smoked plums, tuckahoes, piper cubeba, rhizoma atractylodis, mint, lily, radix glehniae, fructus aurantii, hyacinth beans, radix polygonati officinalis, radix trichosanthis, howthorn, malt, elecampane, galangal and rhizoma picrorhizae. The medicine has an excellent treatment effect on infant anorexia caused by various reasons, and pharmaceutical formulation does not have toxic or side effects. The medicine has effects of nourishing the stomach and the spleen and moving qi to remove food retention, small intestine peristalsis can be promoted effectively, the absorption function of small intestines of the infants is improved, the immunologic function of body cells is improved, the appetite of the infants is improved effectively, and the food intake of the infants can reach that of normal healthful infants.

The invention relates to applications of 2-phenylamino-4-pyrrolidyl-6-(5-(4-methyl-1-piperazinyl)-2-pyridyl)aminopyridino-[3,4-d]pyrimidine in preparation of medicines for promoting small intestine peristalsis. The pharmacological experiment shows that 2-phenylamino-4-pyrrolidyl-6-(5-(4-methyl-1-piperazinyl)-2-pyridyl)aminopyridino-[3,4-d]pyrimidine has a relatively good effect of promoting smallintestine peristalsis, has the outstanding substantive characteristics, and obviously has remarkable progress in preparation of the medicines for promoting small intestine peristalsis.

The invention provides a traditional Chinese medicine composition for treating infantile dyspepsia and phlegm-heat cough and a preparation method thereof. The traditional Chinese medicine compositionis prepared from hawthorn, pinellia ternate, pericarpium citri reticulatae, platycodon grandiflorum, trichosanthes kirilowii maxim, immature bitter orange, mangnolia officinalis, scutellaria baicalensis, fructus forsythiae, semen raphani, semen lepidii, burdock, fructus arctii, the root bark of white mulberry and folium eriobotryae. Pharmacodynamic and clinical tests show that the traditional Chinese medicine composition can increase the content of motilin and promote small intestine propulsion, can achieve the effects of clearing heat and regulating the lung, helping digestion and relieving stasis, preventing phlegm from forming and stopping coughing and treating both symptoms and root causes for patients suffering from infantile dyspepsia and phlegm-heat cough, and is convenient to use,safe and effective.

The invention relates to the technical field of medicines, in particular to application of Gensci073 or analogues thereof. The invention provides the application of Gensci073 or analogues thereof, andparticularly provides application of Gensci073 in preparation of medicines for improving food intake, promoting gastrointestinal motility and treating functional dyspepsia. Researches show that Gensci073 can obviously improve the gastric emptying rate and small intestine propulsion rate of a model rat, and the gastric emptying rate of an animal is reduced along with the increase of the administration dosage of Gensci073 and the small intestine propulsion rate of the animal is increased along with the increase of the administration dosage of Gensci073 within a measured range.

The invention belongs to the technical field of Chinese medicine, and particularly provides a medicine composition for treating constipation. The raw material medicines are composed of cistanche, bighead atractylodes rhizome and semen pruni, and the weight composition range is as follows: 5 to 50 parts of cistanche, 10 to 40 parts of bighead atractylodes rhizome and 10 to 40 parts of semen pruni. The invention further provides a preparation method and specific uses of the medicine composition. Proved by a pharmacological experiment, the medicine composition can obviously shorten first defecating time and increase defecating quantity, and testified by the mice carbon powder boosting experimental research, the medicine composition has the function of promoting small intestine wriggle.